Kairos Pharma Ltd (KAPA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | |
| Cash Flows From Operating Activities | |||
| Net Income | -2,603 | -1,812 | -1,050 |
| Depreciation Amortization | 314 | 216 | 568 |
| Accounts receivable | -2,358 | N/A | N/A |
| Accounts payable and accrued liabilities | 404 | 772 | 129 |
| Other Working Capital | -1,984 | 764 | 129 |
| Other Operating Activity | 2,272 | 141 | -129 |
| Operating Cash Flow | $-3,955 | $81 | $-353 |
| Cash Flows From Investing Activities | |||
| Investing Cash Flow | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||
| Change In Short Term Borrowing | 142 | N/A | 925 |
| Debt Repayment | N/A | N/A | -10 |
| Common Stock Issued | 5,524 | 0 | N/A |
| Other Financing Activity | -532 | -425 | -198 |
| Financing Cash Flow | $5,134 | $-425 | $717 |
| Beginning Cash Position | 93 | 437 | 73 |
| End Cash Position | 1,272 | 93 | 437 |
| Net Cash Flow | $1,179 | $-344 | $364 |
| Free Cash Flow | |||
| Operating Cash Flow | -3,955 | 81 | -353 |
| Free Cash Flow | -3,955 | 81 | -353 |